Archive — US — techcrunch
Samsung may invest in $100M round for medical imaging startup Exo
Samsung's venture unit is considering a $100 million investment in medical imaging startup Exo, which specializes in handheld ultrasound devices using AI technology. Founded in 2015, Exo has raised over $320 million in total funding and is in talks to partner with Samsung Medison Co. on further medical technology development.
Key points
- Samsung's venture investment unit aiming to invest up to $100 million in Exo.
- Sands Capital, Bold Capital, and Qubit Health Capital leading the investment round.
- Exo develops handheld ultrasound devices integrating AI and smartphone technology.
- Launched in 2015, Exo has raised over $320 million in total funding.
- The device enables medical practitioners to scan, document, and share reports efficiently.
- Exo raised $220 million in a Series C round in 2021 and is discussing collaboration with Samsung Medison Co.
Why it matters
- The investment aligns with 2025 IT trends focusing on AI integration in healthcare technologies.
- Handheld medical devices are becoming crucial for on-the-go diagnostics in response to global healthcare needs post-pandemic.
- Previous collaborations between technology and healthcare sectors indicate a growing market demand for innovative medical solutions.
Samsung's potential investment in Exo signifies its commitment to advancing medical technology, particularly the integration of AI and portable devices, which is crucial for enhancing healthcare delivery.